Using data collected by the providers we are able to evaluate safety of medicines and devices. This is a cost effective and efficient way to bring new therapies to the bedside.
Focused on improving the care of patients with heart dysfunction or heart failure. Using both quality improvement and research methodology we are focused on improving care team communication, goal directed medical therapy (GDMT), quality of life and myocardial recovery.
Cardiomyopathy patients have heart muscle problems that affect the ability of the heart to fill with blood and/or eject blood to the body. In some cases, they may have signs and symptoms of heart failure—these patients will need routine monitoring and may need treatment such as cardiac medicines, mechanical devices, or transplantation.
Though pediatric VAD use is increasing, data around outcomes related to patient treatment and device selection decisions is not yet robust enough to inform consistent practices among providers. The authors …
At 11 days old, Juliana waited for a new heart while her mother, Riki, fought breast cancer. Together as mother and daughter, they faced unexpected challenges, braved mounting treatments, endured long waits and recovery. Now, Riki shares their story in thanks to the community of support they found along the way.
“Iron Deficiency Is Associated with Adverse Outcomes in Pediatric Heart Failure” was published in The Journal of Pediatrics on January 1, 2020. As the title suggests, this single-center retrospective cohort …
Iron Deficiency Is Associated with Adverse Outcomes in Pediatric Heart Failure Read More »
See the third part of our “A Family of Big Hearts,” featuring the youngest sibling, Gabe.
Read the second part of our “A Family of Big Hearts,” featuring Lindsey.
Read the first of our three-part series, “A Family of Big Hearts,” featuring Sierra.
